Medicare Enrolled
Dr. Misbah Qadir, MD
Hematology & Oncology · Kinston, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qadir from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qadir?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qadir
Dr. Misbah Qadir is a hematology & oncology specialist in Kinston, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Qadir performed 2,299 Medicare services across 1,047 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qadir received a total of $4,610 from 59 pharmaceutical and/or device companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qadir is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 11% volume in NC
$4,610 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,299
Medicare services
Top 11% in NC for hematology & oncology
1,047
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
451 | $8 | $62 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
370 | $10 | $76 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
236 | $62 | $185 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
201 | $72 | $175 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
157 | $92 | $232 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
110 | $61 | $178 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
85 | $13 | $116 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
85 | $9 | $93 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
85 | $11 | $52 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
76 | $101 | $337 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
74 | $6 | $50 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
66 | $8 | $27 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
48 | $98 | $352 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
33 | $55 | $765 |
| Beta-2 microglobulin level test A blood test that measures the level of beta-2 microglobulin, a protein produced by cells in the body. |
30 | $16 | $79 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
28 | $103 | $357 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
27 | $28 | $127 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
24 | $159 | $786 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
22 | $15 | $89 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
22 | $92 | $256 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
17 | $42 | $587 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
15 | $135 | $499 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
15 | $38 | $96 |
| Red blood cell folate level test A blood test that measures the amount of folic acid stored inside red blood cells to assess long-term folate status. |
11 | $17 | $148 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
11 | $64 | $249 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.1% high complexity
8.1% medium
89.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,610
Total received (2018-2024)
Avg $659/year across 7 years
Top 34% in NC for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
282
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,948 (85.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$662 (14.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$350
2023
$426
2022
$232
2021
$12
2020
$303
2019
$1,968
2018
$1,319
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$125
PFIZER INC.
$67
Daiichi Sankyo Inc.
$36
Merck Sharp & Dohme LLC
$33
Eisai Inc.
$22
Sumitomo Pharma America, Inc.
$20
Janssen Biotech, Inc.
$19
Celgene Corporation
$14
AstraZeneca Pharmaceuticals LP
$13
Top 3 companies account for 65.2% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$476
Novartis Pharmaceuticals Corporation
$356
Incyte Corporation
$316
Genentech USA, Inc.
$294
Janssen Biotech, Inc.
$237
Celgene Corporation
$210
Amgen Inc.
$207
Merck Sharp & Dohme Corporation
$144
Astellas Pharma US Inc
$140
Seattle Genetics, Inc.
$134
Regeneron Healthcare Solutions, Inc.
$125
TESARO, Inc.
$119
Exelixis Inc.
$109
JAZZ PHARMACEUTICALS INC.
$106
Lilly USA, LLC
$105
Novo Nordisk Inc
$100
Daiichi Sankyo Inc.
$98
Clovis Oncology, Inc.
$97
Boehringer Ingelheim Pharmaceuticals, Inc.
$90
GENZYME CORPORATION
$73
AstraZeneca Pharmaceuticals LP
$63
Takeda Pharmaceuticals U.S.A., Inc.
$61
E.R. Squibb & Sons, L.L.C.
$53
Eisai Inc.
$51
Pharmacyclics LLC, An AbbVie Company
$48
Puma Biotechnology, Inc.
$46
Heron Therapeutics, Inc.
$42
EISAI INC.
$38
SANOFI-AVENTIS U.S. LLC
$37
EMD Serono, Inc.
$34
Gilead Sciences, Inc.
$34
Merck Sharp & Dohme LLC
$33
Bayer HealthCare Pharmaceuticals Inc.
$31
TerSera Therapeutics LLC
$31
Seagen Inc.
$28
Janssen Pharmaceuticals, Inc
$26
INSYS Therapeutics Inc
$26
Deciphera Pharmaceuticals Inc.
$25
Dendreon Pharmaceuticals LLC
$24
Alexion Pharmaceuticals, Inc.
$23
MEDIVATION FIELD SOLUTIONS LLC
$22
G1 Therapeutics, Inc.
$21
Ipsen Biopharmaceuticals, Inc
$21
AbbVie, Inc.
$21
Hikma Pharmaceuticals USA
$21
Sumitomo Pharma America, Inc.
$20
ADC Therapeutics America, Inc.
$19
Coherus Biosciences Inc.
$18
BeiGene USA, Inc.
$18
Amarin Pharma Inc.
$17
Mylan Institutional Inc.
$16
Taiho Oncology, Inc.
$14
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
AbbVie Inc.
$14
Kite Pharma, Inc.
$14
Karyopharm Therapeutics Inc.
$14
PharmaEssentia USA Corporation
$14
Verastem, Inc.
$11
Kyowa Kirin, Inc.
$11
Top 3 companies account for 24.9% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Abraxane · Alecensa · Aranesp · Avastin · BESREMI · BOSULIF · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CHANTIX · CINVANTI · COSELA · CREON · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · ELITEK · EMEND · ENTRESTO · EPKINLY · ERLEADA · EVENITY · Enhertu · Erleada · Fulphila · GILOTRIF · Herceptin · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LENVIMA · LIBTAYO · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MVASI · MYLOTARG · Mitigare · Nerlynx · Neulasta · Nplate · OPDIVO · ORGOVYX · Ozempic · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Perjeta · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETACRIT · RYBREVANT · Revlimid · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SOLIQUA · STIOLTO RESPIMAT · SUTENT · SYNDROS · Saxenda · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TOUJEO · TRULANCE · TRULICITY · Tresiba · Trintellix · Trodelvy · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VOTRIENT · Vanflyta · Vascepa · Venclexta · Vitrakvi · XALKORI · XARELTO · XPOVIO · XTANDI · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
5
Per 100K population
9.1
County median income
$44,795
Nearest hospital
UNC LENOIR HEALTH CARE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qadir is a clinical cardiology specialist, with above-average Medicare volume (top 11% in NC), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qadir experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Qadir performed 451 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qadir receive payments from pharmaceutical companies?
Yes. Dr. Qadir received a total of $4,610 from 59 companies across 282 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qadir's costs compare to other hematology & oncology specialists in Kinston?
Dr. Qadir's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qadir) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Kinston
Browse hematology & oncology specialists in Kinston ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NC
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NC
Which NC hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Incyte Corporation Payments to Doctors
See all physicians who received payments from Incyte Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology